19 May 2018 - Amgen and Novartis got it right this time by not charging as much as they could. Their ...
15 May 2018 - Drug companies on Tuesday claimed the Trump administration may not have the legal authority to make ...
11 May 2018 - Today is an important day in the Administration’s collaborative effort to address the rising cost of ...
3 May 2018 - Novartis’ CAR-T therapy Kymriah will be available in the US to adults with relapsed large B-cell ...
19 April 2018 - The FDA has approved nine biosimilars, generic versions of biologic medicines, but only three are available in ...
18 April 2018 - Taking the rebates that it expects to negotiate into consideration, Ultragenyx said that burosumab will cost approximately ...
14 March 2018 - Scott Gottlieb, head of the FDA, has emerged as a key figure in the Trump administration’s ...
7 March 2018 - FDA has approved nine biosimilars, only three for sale in U.S. ...
23 February 2018 - When Teva Pharmaceuticals announced recently that it would begin selling a copycat version of Syprine — ...
15 February 2018 - FDA Commissioner Scott Gottlieb said he will do everything “within my lane” to combat high drug ...
18 January 2018 - Cost of drug Emflaza, which came under scrutiny last year, will go up by 9% for regular ...
6 January 2018 - FDA generics push comes amid quality enforcement woes in India. ...
6 January 2018 - Humira is the best-selling prescription drug in the world. You may have seen the commercials. ...
3 January 2018 - A landmark gene therapy to treat a rare, inherited form of blindness will cost $850,000 — ...
3 January 2018 - The FDA today announced additional steps to encourage generic competition as part of our continued implementation of ...